808. Oncolytic Adenoviral Vector Targeted to Hepatocellular Carcinoma Expressing Low Levels of miR-122

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)37381-6
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Expression of miR-122 Mediated by Adenoviral Vector Induces Apoptosis and Cell Cycle Arrest of Cancer Cells.

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells Through Regulating the Tumor Metabolism

PLoS ONE
Multidisciplinary
2016English

Adenoviral Vector Expressing Murine Β-Defensin 2 Enhances Immunogenicity of an Adenoviral Vector Based H5N1 Influenza Vaccine in Aged Mice

Virus Research
Cancer ResearchVirologyInfectious Diseases
2013English

Endothelial Cell-Targeted Adenoviral Vector for Suppressing Breast Malignancies

2005English

Lactosylated Gramicidin-Based Lipid Nanoparticles (Lac-Gln) for Targeted Delivery of Anti-miR-155 to Hepatocellular Carcinoma

Journal of Controlled Release
Pharmaceutical Science
2013English

Oncolytic Adenoviral Vector Carrying the Cytosine Deaminase Gene for Melanoma Gene Therapy

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2006English

Targeted Therapy in Hepatocellular Carcinoma

International Journal of Hepatology
Hepatology
2011English

Molecular Targeted Therapy of Hepatocellular Carcinoma

Journal of Cancer Therapy
2013English

Targeted Delivery of miR-199a-3p Using Self-Assembled Dipeptide Nanoparticles Efficiently Reduces Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy